Having trouble accessing articles? Reset your cache.

Sutent sunitinib: Preliminary Phase III data

Top-line data from the double-blind, international Phase III SUN 1087 trial in about 956 NSCLC patients previously treated with a platinum-based chemotherapy regimen showed that

Read the full 252 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE